Neurocrine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids.
NBIX Key Statistics
NBIX News
Analysts are intrested in these 5 stocks: ( (PEP) ), ( (HRL) ), ( (NBIX) ), ( (EXC) ) and ( (AUR) ). Here is a breakdown of their recent ratings and the rationa...
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track...
A physician survey for Neurocrine Biosciences Inc's NBIX Crenessity suggests "strong uptake across all patient segments," according to Needham. The Neurocrine...
Analyst ratings
81%
of 27 ratingsMore NBIX News
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...
Needham analyst Ami Fadia upgraded Neurocrine (NBIX) to Buy from Hold with a $138 price target Published first on TheFly – the ultimate source for real-time, m...
As previously reported, RBC Capital upgraded Neurocrine (NBIX) to Outperform from Sector Perform with a price target of $137, down from $138. Weakness in the sh...